Literature DB >> 25264192

DNA-PKcs-SIN1 complexation mediates low-dose X-ray irradiation (LDI)-induced Akt activation and osteoblast differentiation.

Yong Xu1, Shi-Ji Fang1, Li-Juan Zhu2, Lun-Qing Zhu3, Xiao-Zhong Zhou4.   

Abstract

Low-dose irradiation (LDI) induces osteoblast differentiation, however the underlying mechanisms are not fully understood. In this study, we explored the potential role of DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-Akt signaling in LDI-induced osteoblast differentiation. We confirmed that LDI promoted mouse calvarial osteoblast differentiation, which was detected by increased alkaline phosphatase (ALP) activity as well as mRNA expression of type I collagen (Col I) and runt-related transcription factor 2 (Runx2). In mouse osteoblasts, LDI (1Gy) induced phosphorylation of DNA-PKcs and Akt (mainly at Ser-473). The kinase inhibitors against DNA-PKcs (NU-7026 and NU-7441) or Akt (LY294002, perifosine and MK-2206), as well as partial depletion of DNA-PKcs or Akt1 by targeted-shRNA, dramatically inhibited LDI-induced Akt activation and mouse osteoblast differentiation. Further, siRNA-knockdown of SIN1, a key component of mTOR complex 2 (mTORC2), also inhibited LDI-induced Akt Ser-473 phosphorylation as well as ALP activity increase and Col I/Runx2 expression in mouse osteoblasts. Co-immunoprecipitation (Co-IP) assay results demonstrated that LDI-induced DNA-PKcs-SIN1 complexation, which was inhibited by NU-7441 or SIN1 siRNA-knockdown in mouse osteoblasts. In summary, our data suggest that DNA-PKcs-SIN1 complexation-mediated Akt activation (Ser-473 phosphorylation) is required for mouse osteoblast differentiation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA–PKcs; Low-dose irradiation (LDI); Osteoblast differentiation; mTORC2–SIN1 and Akt

Mesh:

Substances:

Year:  2014        PMID: 25264192     DOI: 10.1016/j.bbrc.2014.09.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Inhibition of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) stimulates osteoblastogenesis by potentiating bone morphogenetic protein 2 (BMP2) responses.

Authors:  Theresa Farhat; Amel Dudakovic; Jay H Chung; Andre J van Wijnen; René St-Arnaud
Journal:  J Cell Physiol       Date:  2020-07-19       Impact factor: 6.384

2.  Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation.

Authors:  Bing Zheng; Jia-Hui Mao; Xiao-Qing Li; Lin Qian; Hua Zhu; Dong-Hua Gu; Xiao-Dong Pan
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

3.  Identification of DNA-PKcs as a primary resistance factor of TIC10 in hepatocellular carcinoma cells.

Authors:  Long Cheng; Yuan-Yuan Liu; Pei-Hua Lu; Yi Peng; Qiang Yuan; Xin-Shi Gu; Yong Jin; Min-Bin Chen; Xu-Ming Bai
Journal:  Oncotarget       Date:  2017-04-25

4.  Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.

Authors:  Yun-Fang Zhen; Song-Tao Li; Yun-Rong Zhu; Xiao-Dong Wang; Xiao-Zhong Zhou; Lun-Qing Zhu
Journal:  Oncotarget       Date:  2016-11-29

5.  Effects of low-dose X-ray irradiation on activated macrophages and their possible signal pathways.

Authors:  Jian Li; Zhen-Yu Yao; Chang She; Jian Li; Bin Ten; Chang Liu; Shu-Bin Lin; Qi-Rong Dong; Pei-Gen Ren
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.